This report contains market size and forecasts of ADHD Drugs in global, including the following market information:
Global ADHD Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global ADHD Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five ADHD Drugs companies in 2021 (%)
The global ADHD Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Stimulants(Amphetamines, Methylphenidate) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of ADHD Drugs include Eli Lilly, Janssen Pharmaceuticals, Inc., Takeda, Perdue Pharma, Glaxosmith Kline, Novartis, Celltech Group and Johnson & Johnson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the ADHD Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global ADHD Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global ADHD Drugs Market Segment Percentages, by Type, 2021 (%)
Stimulants(Amphetamines, Methylphenidate)
Non-Stimulants
Antidepressants
Blood Pressure Medicines
Global ADHD Drugs Market, by User, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global ADHD Drugs Market Segment Percentages, by User, 2021 (%)
Adults
Children
Global ADHD Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global ADHD Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies ADHD Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies ADHD Drugs revenues share in global market, 2021 (%)
Key companies ADHD Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies ADHD Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Janssen Pharmaceuticals, Inc.
Takeda
Perdue Pharma
Glaxosmith Kline
Novartis
Celltech Group
Johnson & Johnson